News

AstraZeneca announces that it will invest $4.5 billion in its new manufacturing facility in Virginia, a proposed increase of $500m to support the enhanced manufacturing capability of a broader range of medicines including cancer treatments. This is part of the historic $50 billion investment announced in July 2025. The new facility will be located at …

Adial Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of addiction and related disorders, today announced the successful completion of the analytical validation of a cheek swab collection method for testing patients for both clinical trial usage as well as future commercial application. This major step marks a …

The University of Virginia today celebrates a key milestone in the construction of the Paul and Diane Manning Institute of Biotechnology’s 350,000-square-foot facility at Fontaine Research Park with a “topping off” ceremony at which the final steel beam will be placed. “I am delighted to be one step closer to opening the Manning Institute’s state-of-the-art new facility and …